http://www.usnews.com/news/articles/2015/11/04/wuxi-nextcode-to-sequence-genomes-of-1-000-cancer-patients
Posts By: admin
‘Exceptional responders’ to cancer drugs draw scrutiny from scientists
http://www.washingtonpost.com/national/health-science/looking-for-answers-in-cancers-exceptional-responders/2015/06/13/9cf0ec78-0571-11e5-a428-c984eb077d4e_story.html
New chemical technology boosts potency of targeted cancer therapy
http://www.dana-farber.org/Newsroom/News-Releases/new-chemical-technology-boosts-potency-of-targeted-cancer-therapy.aspx
International study of advanced prostate cancer genome finds abundance of potential targets for drug therapy
http://www.dana-farber.org/Newsroom/News-Releases/international-study-of-advanced-prostate-cancer-genome-finds-abundance-of-potential-targets-for-drug-therapy.aspx
New drug combination extends survival of patients with metastatic colorectal cancer
http://www.dana-farber.org/Newsroom/News-Releases/new-drug-combination-extends-survival-of-patients-with-metastatic-colorectal-cancer.aspx
New targeted drug promising treatment option in resistant EGFR-positive lung cancers
http://www.dana-farber.org/Newsroom/News-Releases/New-targeted-drug-promising-treatment-option-in-resistant-EGFR-positive-lung-cancers.aspx
Webchat: The Latest in Precision Medicine and Lung Cancer
http://www.dana-farber.org/Health-Library/Webchat–The-Latest-in-Precision-Medicine-and-Lung-Cancer.aspx
Minor gene mutations can produce extensive disruption of protein interactions, study finds
http://www.dana-farber.org/Newsroom/News-Releases/minor-gene-mutations-can-produce-extensive-disruption-of-protein-interactions-study-finds.aspx
Olaparib and investigational PI3K inhibitor BKM120 combination active against ovarian and breast cancer subtypes
http://www.dana-farber.org/Newsroom/News-Releases/olaparib-and-investigational-pi3k-inhibitor-bkm120-combination-active-against-ovarian-and-breast-cancer-subtypes.aspx
D’Andrea selected to lead new SU2C Ovarian Cancer Dream Team
http://www.dana-farber.org/Newsroom/News-Releases/dana-farbers-dandrea-selected-to-lead-new-su2c-ovarian-cancer-dream-team.aspx
Unregulated web marketing of genetic tests for personalized cancer care raises concerns in new study
http://www.dana-farber.org/Newsroom/News-Releases/Unregulated-web-marketing-of-genetic-tests-for-personalized-cancer-care-raises-concerns-in-new-study.aspx
Novel precision medicine tool could help personalize cancer treatments
http://www.dana-farber.org/Newsroom/News-Releases/novel-precision-medicine-tool-could-help-personalize-cancer-treatments.aspx
Five things you should know about precision medicine
http://www.dana-farber.org/Newsroom/News-Releases/Dana-Farber-experts-share-five-things-you-should-know-about-precision-medicine.aspx
Study identifies promising drug target in certain breast and ovarian cancers
http://www.dana-farber.org/Newsroom/News-Releases/study-identifies-promising-drug-target-in-certain-breast-and-ovarian-cancers.aspx
Collaborative Effort Helps Develop More Effective Treatment for Brain Tumors
Collaborative Effort Helps Develop More Effective Treatment for Brain Tumors
Large study catalogs genetic culprits in head and neck cancers
http://www.dana-farber.org/Newsroom/News-Releases/large-study-catalogs-genetic-culprits-in-head-and-neck-cancers.aspx
New Immunotherapy Vaccines Show Promise in Treating Brain Tumors
New Immunotherapy Vaccines Show Promise in Treating Brain Tumors
Combined therapy can reduce chance of recurrence in women with small, HER2+ breast tumors, study shows
http://www.dana-farber.org/Newsroom/News-Releases/combined-therapy-can-reduce-chance-of-recurrence-in-women-with-small-her-2-positive-breast-tumors.aspx
Common genetic variations may contribute to treatment-related cognitive problems in children with leukemia
http://www.dana-farber.org/Newsroom/News-Releases/common-genetic-variations-may-contribute-to-treatment-related-cognitive-problems-in-children-with-leukemia.aspx
Disorder in gene-control system is a defining characteristic of cancer, study finds
http://www.dana-farber.org/Newsroom/News-Releases/Disorder-in-gene-control-system-is-a-defining-characteristic-of-cancer-study-finds.aspx
Unsuspected gene found frequently mutated in colorectal, endometrial cancers
http://www.dana-farber.org/Newsroom/News-Releases/Unsuspected-gene-found-frequently-mutated-in-colorectal-endometrial-cancers.aspx
Precision medicine for lung cancer marks tenth anniversary
http://www.dana-farber.org/Newsroom/News-Releases/precision-medicine-for-lung-cancer-marks-tenth-anniversary.aspx
Targeted therapy boosts lung cancer outcomes
http://www.dana-farber.org/NewsRoom/News-Releases/targeted-therapy-boosts-lung-cancer-outcomes.aspx
Genomic sequencing identifies mutant ‘drivers’ of common brain tumor
http://www.dana-farber.org/Newsroom/News-Releases/Genomic-sequencing-identifies-mutant-drivers-of-common-brain-tumor.aspx
